↓ Skip to main content

Improved Prognosis for Older Adolescents With Acute Lymphoblastic Leukemia

Overview of attention for article published in Journal of Clinical Oncology, February 2011
Altmetric Badge

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
93 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Improved Prognosis for Older Adolescents With Acute Lymphoblastic Leukemia
Published in
Journal of Clinical Oncology, February 2011
DOI 10.1200/jco.2010.32.0325
Pubmed ID
Authors

Ching-Hon Pui, Deqing Pei, Dario Campana, W. Paul Bowman, John T. Sandlund, Sue C. Kaste, Raul C. Ribeiro, Jeffrey E. Rubnitz, Elaine Coustan-Smith, Sima Jeha, Cheng, Monika L. Metzger, Deepa Bhojwani, Hiroto Inaba, Susana C. Raimondi, Mihaela Onciu, Scott C. Howard, Wing Leung, James R. Downing, William E. Evans, Mary V. Relling

Abstract

The prognosis for older adolescents and young adults with acute lymphoblastic leukemia (ALL) has been historically much worse than that for younger patients. We reviewed the outcome of older adolescents (age 15 to 18 years) treated in four consecutive Total Therapy studies to determine if recent improved treatment extended to this high-risk group.

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 2 2%
United Kingdom 1 1%
Malaysia 1 1%
Australia 1 1%
Italy 1 1%
Spain 1 1%
Austria 1 1%
Unknown 85 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 18%
Professor 10 11%
Student > Master 10 11%
Unspecified 10 11%
Other 9 10%
Other 37 40%
Readers by discipline Count As %
Medicine and Dentistry 54 58%
Agricultural and Biological Sciences 12 13%
Unspecified 10 11%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Biochemistry, Genetics and Molecular Biology 5 5%
Other 6 6%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2011.
All research outputs
#7,791,378
of 12,418,579 outputs
Outputs from Journal of Clinical Oncology
#10,628
of 12,646 outputs
Outputs of similar age
#44,244
of 70,912 outputs
Outputs of similar age from Journal of Clinical Oncology
#77
of 97 outputs
Altmetric has tracked 12,418,579 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,646 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 70,912 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.